Stjärne Aspelund Anna, Hammarström Helena, Inghammar Malin, Larsson Hillevi, Hansson Lennart, Riise Gerdt C, Friman Vanda, Christensson Bertil, Påhlman Lisa I
Division of Infection Medicine, Hospital of Helsingborg, Helsingborg, Sweden.
Division of Infection Medicine, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden.
Transpl Infect Dis. 2018 Dec;20(6):e12973. doi: 10.1111/tid.12973. Epub 2018 Aug 27.
Lung transplant patients experience a high risk of airway infections and microbial colonization of the lung due to constant exposure to the environment through inhaled microorganisms, denervation, reduced ciliary transport, and decreased cough.
In this nationwide prospective study on Swedish lung transplant patients, we evaluated the microbiological panorama of bacteria, fungi, and virus found in bronchoalveolar lavage fluid (BALF) obtained the first year after lung transplantation (LTx). Differences in microbiological findings depending of concomitant signs of infection and background factors were assessed.
A total of 470 bronchoscopies from 126 patients were evaluated. Sixty-two percent (n = 293) of BALF samples had positive microbiological finding(s). Forty-six percent (n = 217) had bacterial growth, 29% (n = 137) fungal growth, and 9% (n = 43) were positive in viral PCR. In 38% of BALF samples (n = 181), a single microbe was found, whereas a combination of bacteria, fungi or virus was found in 24% (n = 112) of bronchoscopies. The most common microbiological findings were Candida albicans, Pseudomonas aeruginosa and coagulase negative Staphylococcus (in 42 (33%), 36 (29%), and 25 (20%) patients, respectively). Microbiological findings were similar in BALF from patients with and without signs of lung infection and the frequency of multidrug resistant (MDR) bacteria was low. No significant association was found between background factors and time to first lung infection.
This study gives important epidemiologic insights and reinforces that microbiological findings have to be evaluated in the light of clinical symptoms and endobronchial appearance in the assessment of lung infections in lung transplant patients.
由于通过吸入微生物持续接触环境、去神经支配、纤毛运输减少和咳嗽减弱,肺移植患者发生气道感染和肺部微生物定植的风险很高。
在这项针对瑞典肺移植患者的全国性前瞻性研究中,我们评估了肺移植(LTx)后第一年获得的支气管肺泡灌洗(BALF)液中发现的细菌、真菌和病毒的微生物全貌。评估了根据感染伴随体征和背景因素的微生物学发现差异。
共评估了126例患者的470次支气管镜检查。62%(n = 293)的BALF样本有阳性微生物学发现。46%(n = 217)有细菌生长,29%(n = 137)有真菌生长,9%(n = 43)病毒PCR呈阳性。在38%的BALF样本(n = 181)中发现单一微生物,而在24%(n = 112)的支气管镜检查中发现细菌、真菌或病毒的组合。最常见的微生物学发现是白色念珠菌、铜绿假单胞菌和凝固酶阴性葡萄球菌(分别在42例(3%)、36例(29%)和25例(20%)患者中)。有和没有肺部感染体征的患者的BALF中的微生物学发现相似,多重耐药(MDR)细菌的频率较低。未发现背景因素与首次肺部感染时间之间存在显著关联。
本研究提供了重要的流行病学见解,并强调在评估肺移植患者的肺部感染时,必须根据临床症状和支气管内表现来评估微生物学发现。